An Observational Study to Assess the Predictors of Cardiac Dysfunction in Type 2 Diabetes Patients

Amit Kumar  Chaudhary; Raj Kishore  Singh; Mudit  Chauhan; Aradhana  Singh

Amit Kumar Chaudhary Junior Resident, 3rd Year, BRD Medical College, Gorakhpur, Uttar Pradesh, India
Raj Kishore Singh Professor, General Medicine, BRD Medical College, Gorakhpur, Uttar Pradesh, India
Mudit Chauhan Senior Resident, Department of Community Medicine, BRD Medical College, Gorakhpur, Uttar Pradesh, India
Aradhana Singh Professor, Obstetrics & Gynaecology, BRD Medical College, Gorakhpur, Uttar Pradesh, India

Keywords: Cardiac Failure, Heart failure, Diabetes mellitus, Diabetes mellitus Type-2

Abstract

Introduction: Diabetes mellitus is a chronic metabolic disorder characterised by elevated blood glucose levels (hyperglycaemia) resulting from either insufficient insulin production or ineffective insulin utilisation by the body. Cardiac dysfunction refers to abnormalities in the structure or function of the heart, leading to impaired pumping ability and compromised circulation. The relationship between diabetes mellitus and cardiac dysfunction is complex and involves multiple factors, including metabolic, molecular, and cellular mechanisms. Aim: The aim of this study was to identify the predictors of cardiac dysfunction in patients with type 2 diabetes mellitus (T2DM). Material and Methods: The study employed an observational design and included a sample size of 284 participants with type 2 diabetes. It included T2DM patients (> 10 years of duration of the disease) who were more than 40 years of age. Result: The results showed a significant positive association between the age group of 61-80 years and abnormal/ elevated levels of B-type natriuretic peptide (BNP) [odds ratio (OR): 2.32; confidence interval (CI): 1.013 ± 3.301; p value: 0.039]. Furthermore, an increase in the duration of T2DM (21-30 years) was significantly associated with abnormal/ elevated BNP levels (> 100) [OR: 3.283; CI: 1.704 ± 3.827; p value: 0.003]. Conclusion: This study links BNP to ejection fraction (EF) in T2DM patients without heart failure symptoms. It also shows that elevated BNP is associated with reduced EF, and normal BNP is linked to preserved EF. It was seen that age, T2DM duration, and HbA1c impact BNP levels. Longer T2DM duration was found to be associated with lower EF. How to cite this article: Chaudhary AK, Singh RK, Singh A, Chauhan M. An Observational Study to Assess the Predictors of Cardiac Dysfunction in Type 2 Diabetes Patients. J Adv Res Med. 2023;10(1):1-8. DOI: https://doi.org/10.24321/2349.7181.202302

References

American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2021. Diabetes Care. 2021 Jan;44(Suppl 1):S151-67. [PubMed] [Google Scholar]

Standl E, Schnell O, McGuire DK. Heart failure considerations of antihyperglycemic medications for type 2 diabetes. Circ Res. 2016;118(11):1830-43. [PubMed] [Google Scholar]

Cavender MA, Steg PG, Smith Jr SC, Eagle K, Ohman EM, Goto S, Kuder J, Im K, Wilson PW, Bhatt DL; REACH

Registry Investigators. Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the Reduction of Atherothrombosis for Continued Health (REACH)

Registry. Circulation. 2015;132(10):923-31. [PubMed] [Google Scholar]

Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, Deswal A, Dickson VV, Kosiborod MN, Lekavich CL, McCoy RG, Mentz RJ, Piña IL; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; the Heart Failure Society of America. Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation. 2019;140(7):e294-324. [PubMed] [Google Scholar]

Marwick TH, Ritchie R, Shaw JE, Kaye D. Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy. J Am Coll Cardiol. 2018 Jan;71(3):339-51. [PubMed] [Google Scholar]

Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes

care, 1999-2010. N Engl J Med. 2013;368(17):1613-24. [PubMed] [Google Scholar]

Dunlay SM, Roger VL, Killian JM, Weston SA, Schulte PJ, Subramaniam AV, Blecker SB, Redfield MM. Advanced heart failure epidemiology and outcomes: a population based study. JACC Heart Fail. 2021 Oct;9(10):722-32. [PubMed] [Google Scholar]

Venkataraman K, Kannan AT, Mohan V. Challenges in diabetes management with particular reference

to India. Int J Diabetes Dev Ctries. 2009;29(3):103-9. [PubMed] [Google Scholar]

Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus:

atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations. Circulation [Internet]. 2016 Jun 14 [cited 2023 May 19];133(24):2459-502. Available from: https://www.ahajournals.org/doi/ abs/10.1161/CIRCULATIONAHA.116.022194 [PubMed] [Google Scholar]

Gong H, Wang X, Ling Y, Shi Y, Shi H. Prognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function. Exp Ther Med. 2014 Jun;7(6):1506-12. [PubMed] [Google Scholar]

Boerrigter G, Costello-Boerrigter LC, Burnett Jr JC. Natriuretic peptides in the diagnosis and management of chronic heart failure. Heart Fail Clin. 2009 Oct;5(4):501-14. [PubMed] [Google Scholar]

Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006

Jun;92(6):843-9. [PubMed] [Google Scholar] 13. Rosano GM, Vitale C, Seferovic P. Heart failure in patients with diabetes mellitus. Card Fail Rev. 2017 Apr;3(1):52-5. [PubMed] [Google Scholar]

Packer M. Heart failure: the most important, preventable, and treatable cardiovascular complication

of type 2 diabetes. Diabetes Care. 2018 Jan;41(1):11-3. [PubMed] [Google Scholar]

Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol. 2003 Aug 20;42(4):728-35. [PubMed] [Google Scholar]

Fringu FI, Sitar-Taut AV, Caloian B, Zdrenghea D, Comsa D, Gusetu G, Pop D. The role of NT pro-BNP in the evaluation of diabetic patients with heart failure. Acta Endocrinol (Buchar). 2020 Apr-Jun;16(2):183-91. [PubMed] [Google Scholar]